发明名称 Method of screening drugs that promote LOXL1 expression
摘要 The present invention discloses a drug screening method, drugs promoting extracellular matrix protein crosslinking and their applications, the said drug screening method, is used to screen out materials promoting the expression of LOXL1 gene, wherein, the said drug screening method contains the following steps: A, Construct the 2nd generation lentiviral vector used to control the ZsGreen expression by human LOXL 1 gene promoter. B, Infect human fibroblasts with the 2nd generation lentiviral vector, and construct the new human fibroblasts which integrate PLOXL1-ZsGreen components. C, Drug screening: Inoculate the said human fibroblasts integrating PLOXL1-ZsGreen components into culture medium. Add the analyte into the cell culture medium containing human fibroblast cells. After culturing, detect the green fluorescence intensity of these fibroblast cells, then decide if the analyte promotes LOXL1 gene expression by checking if the green fluorescence intensity is increased. The method provided by the present invention is easy to operate and widely applicable.
申请公布号 US9481915(B2) 申请公布日期 2016.11.01
申请号 US201213884272 申请日期 2012.12.28
申请人 SUZHOU BIOWISETECH CO., LTD. 发明人 Liu Xiaoqing;Ying Ming;Jian Lihua
分类号 C12N5/00;C12Q1/68;G01N33/50;A23L1/30;A23L1/29;A61K45/06;A61K36/00 主分类号 C12N5/00
代理机构 Anova Law Group, PLLC 代理人 Anova Law Group, PLLC
主权项 1. A method for screening drugs that promote LOXL1 gene expression in vitro, comprising: a) replacing the CMV-IE promoter of pLVX-IRES-ZsGreen1 with a LOXL1 promoter to obtain pLenti-PLOXL1-ZsGreen; b) transfecting isolated fibroblasts with the pLenti-PLOXL1-ZsGreen lentiviral vector; c) administering a drug dissolved in DMSO to the transfected fibroblasts; d) detecting green fluorescence intensity of the transfected fibroblasts of step c), wherein increased green fluorescence intensity indicates the drug promotes LOXL1 gene expression.
地址 Suzhou CN